Pulmonary Drug Delivery Systems Market - Global Outlook and Forecast 2022-2028
Report Code: KNJ1145853 No. of Pages: 116 Category: Medical Devices
Publisher: Date of Publish:
Publisher: Date of Publish:
Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
This report contains market size and forecasts of Pulmonary Drug Delivery Systems in global, including the following market information:
Global Pulmonary Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pulmonary Drug Delivery Systems Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Pulmonary Drug Delivery Systems companies in 2021 (%)
The global Pulmonary Drug Delivery Systems market was valued at 3134.3 million in 2021 and is projected to reach US$ 4129.9 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nebulizers Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pulmonary Drug Delivery Systems include 3M, GSK, AstraZeneca, Cipla, Chiesi, Boehringer Ingelheim, Aptar, Novartis and Philips Respironics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Global Pulmonary Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
COPD
Asthma
Others
Global Pulmonary Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Pulmonary Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Drug Delivery Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pulmonary Drug Delivery Systems revenues share in global market, 2021 (%)
Key companies Pulmonary Drug Delivery Systems sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Pulmonary Drug Delivery Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Systems Overall Market Size
2.1 Global Pulmonary Drug Delivery Systems Market Size: 2021 VS 2028
2.2 Global Pulmonary Drug Delivery Systems Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pulmonary Drug Delivery Systems Sales: 2017-2028
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Systems Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Systems Revenue by Companies
3.4 Global Pulmonary Drug Delivery Systems Sales by Companies
3.5 Global Pulmonary Drug Delivery Systems Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Systems Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pulmonary Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Systems Market Size Markets, 2021 & 2028
4.1.2 Nebulizers
4.1.3 Dry Powder Inhaler (DPI)
4.1.4 Metered Dose Inhaler (MDI)
4.2 By Type - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2017-2022
4.2.2 By Type - Global Pulmonary Drug Delivery Systems Revenue, 2023-2028
4.2.3 By Type - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
4.3 By Type - Global Pulmonary Drug Delivery Systems Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Systems Sales, 2017-2022
4.3.2 By Type - Global Pulmonary Drug Delivery Systems Sales, 2023-2028
4.3.3 By Type - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
4.4 By Type - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Systems Market Size, 2021 & 2028
5.1.2 COPD
5.1.3 Asthma
5.1.4 Others
5.2 By Application - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2017-2022
5.2.2 By Application - Global Pulmonary Drug Delivery Systems Revenue, 2023-2028
5.2.3 By Application - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
5.3 By Application - Global Pulmonary Drug Delivery Systems Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Systems Sales, 2017-2022
5.3.2 By Application - Global Pulmonary Drug Delivery Systems Sales, 2023-2028
5.3.3 By Application - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
5.4 By Application - Global Pulmonary Drug Delivery Systems Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Pulmonary Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2017-2022
6.2.2 By Region - Global Pulmonary Drug Delivery Systems Revenue, 2023-2028
6.2.3 By Region - Global Pulmonary Drug Delivery Systems Revenue Market Share, 2017-2028
6.3 By Region - Global Pulmonary Drug Delivery Systems Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Systems Sales, 2017-2022
6.3.2 By Region - Global Pulmonary Drug Delivery Systems Sales, 2023-2028
6.3.3 By Region - Global Pulmonary Drug Delivery Systems Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.4.2 By Country - North America Pulmonary Drug Delivery Systems Sales, 2017-2028
6.4.3 US Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.4.4 Canada Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.4.5 Mexico Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.5.2 By Country - Europe Pulmonary Drug Delivery Systems Sales, 2017-2028
6.5.3 Germany Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.4 France Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.5 U.K. Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.6 Italy Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.7 Russia Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.8 Nordic Countries Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.5.9 Benelux Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.6.2 By Region - Asia Pulmonary Drug Delivery Systems Sales, 2017-2028
6.6.3 China Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.4 Japan Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.5 South Korea Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.6 Southeast Asia Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.6.7 India Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.7.2 By Country - South America Pulmonary Drug Delivery Systems Sales, 2017-2028
6.7.3 Brazil Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.7.4 Argentina Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Systems Sales, 2017-2028
6.8.3 Turkey Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8.4 Israel Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8.5 Saudi Arabia Pulmonary Drug Delivery Systems Market Size, 2017-2028
6.8.6 UAE Pulmonary Drug Delivery Systems Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Pulmonary Drug Delivery Systems Major Product Offerings
7.1.4 3M Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.1.5 3M Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pulmonary Drug Delivery Systems Major Product Offerings
7.2.4 GSK Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.2.5 GSK Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Pulmonary Drug Delivery Systems Major Product Offerings
7.3.4 AstraZeneca Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.3.5 AstraZeneca Key News
7.4 Cipla
7.4.1 Cipla Corporate Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Pulmonary Drug Delivery Systems Major Product Offerings
7.4.4 Cipla Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.4.5 Cipla Key News
7.5 Chiesi
7.5.1 Chiesi Corporate Summary
7.5.2 Chiesi Business Overview
7.5.3 Chiesi Pulmonary Drug Delivery Systems Major Product Offerings
7.5.4 Chiesi Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.5.5 Chiesi Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Major Product Offerings
7.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Aptar
7.7.1 Aptar Corporate Summary
7.7.2 Aptar Business Overview
7.7.3 Aptar Pulmonary Drug Delivery Systems Major Product Offerings
7.7.4 Aptar Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.7.5 Aptar Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Pulmonary Drug Delivery Systems Major Product Offerings
7.8.4 Novartis Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Philips Respironics
7.9.1 Philips Respironics Corporate Summary
7.9.2 Philips Respironics Business Overview
7.9.3 Philips Respironics Pulmonary Drug Delivery Systems Major Product Offerings
7.9.4 Philips Respironics Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.9.5 Philips Respironics Key News
7.10 Omron Healthcare
7.10.1 Omron Healthcare Corporate Summary
7.10.2 Omron Healthcare Business Overview
7.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Major Product Offerings
7.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.10.5 Omron Healthcare Key News
7.11 PARI
7.11.1 PARI Corporate Summary
7.11.2 PARI Pulmonary Drug Delivery Systems Business Overview
7.11.3 PARI Pulmonary Drug Delivery Systems Major Product Offerings
7.11.4 PARI Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.11.5 PARI Key News
7.12 Skyepharma
7.12.1 Skyepharma Corporate Summary
7.12.2 Skyepharma Pulmonary Drug Delivery Systems Business Overview
7.12.3 Skyepharma Pulmonary Drug Delivery Systems Major Product Offerings
7.12.4 Skyepharma Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.12.5 Skyepharma Key News
7.13 CareFusion
7.13.1 CareFusion Corporate Summary
7.13.2 CareFusion Pulmonary Drug Delivery Systems Business Overview
7.13.3 CareFusion Pulmonary Drug Delivery Systems Major Product Offerings
7.13.4 CareFusion Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.13.5 CareFusion Key News
7.14 Shanghai Huarui
7.14.1 Shanghai Huarui Corporate Summary
7.14.2 Shanghai Huarui Business Overview
7.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Major Product Offerings
7.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Huarui Key News
7.15 Taian Character
7.15.1 Taian Character Corporate Summary
7.15.2 Taian Character Business Overview
7.15.3 Taian Character Pulmonary Drug Delivery Systems Major Product Offerings
7.15.4 Taian Character Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.15.5 Taian Character Key News
7.16 Chia Tai Tianqing
7.16.1 Chia Tai Tianqing Corporate Summary
7.16.2 Chia Tai Tianqing Business Overview
7.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Major Product Offerings
7.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales and Revenue in Global (2017-2022)
7.16.5 Chia Tai Tianqing Key News
8 Global Pulmonary Drug Delivery Systems Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Systems Production Capacity, 2017-2028
8.2 Pulmonary Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Systems Supply Chain Analysis
10.1 Pulmonary Drug Delivery Systems Industry Value Chain
10.2 Pulmonary Drug Delivery Systems Upstream Market
10.3 Pulmonary Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com